Hypericin - Moligand™, ≥96% , CAS No.548-04-9

CAS: 548-04-9 Cat. No.: H110188 Molecular Weight: 504.44 Beilstein Registry Number: 1917913 EC Number: 208-941-0

GRADE & PURITY Moligand™, ≥96%

Synonyms

CCG-36081 | 1:6:8:10:11:13-hexahydroxy-3:4-dimethyl-meso-naphthodianthrene-7:14-dione | 4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethylnaphthodianthrone | hypericin | DTXSID40203270 | Hypericin & Visible light | LMPK13040001 | NCI60_006799 | M01850 | MFCD0001668

Storage

Store at 2-8°C,Protected from light

Shipped In

Wet ice

Specifications

Synonyms

CCG-36081 | 1:6:8:10:11:13-hexahydroxy-3:4-dimethyl-meso-naphthodianthrene-7:14-dione | 4, 5, 7, 4', 5', 7'-Hexahydroxy-2, 2'-dimethylnaphthodianthrone | hypericin | DTXSID40203270 | Hypericin & Visible light | LMPK13040001 | NCI60_006799 | M01850 | MFCD0001668

Specifications & Purity

Moligand™, ≥96%

Biochemical and Physiological Mechanisms

Selective PKC inhibitor (IC 50 = 3.3 μM). Antiviral agent. Potent tyrosine kinase inhibitor (IC 50 = 7.5 μM). Potent CKII inhibitor (IC 50 = 6 nM). Inactivates enveloped viruses including HIV. Promotes VEGF and TGF-β production.

Storage

Store at 2-8°C, Protected from light

Shipped In

Wet ice

This product requires cold chain shipping. Ground and other economy services are not available.

Grade

Moligand™

Note

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Purity

≥96%

Names and Identifiers

• Pubchem Sid: 504750693
• Pubchem Sid Url: https://pubchem.ncbi.nlm.nih.gov/substance/504750693
• Canonical Smiles: CC1=CC(=O)C2=C(C3=C(C=C(C4=C3C5=C2C1=C6C(=CC(=O)C7=C(C8=C(C=C(C4=C8C5=C67)O)O)O)C)O)O)O
• IUPAC Name: 9,11,13,16,18,20-hexahydroxy-5,24-dimethyloctacyclo[13.11.1.12,10.03,8.04,25.019,27.021,26.014,28]octacosa-1(26),2,4(25),5,8,10,12,14(28),15(27),16,18,20,23-tridecaene-7,22-dione
• InChIKey: YDOIFHVUBCIUHF-UHFFFAOYSA-N
• INCHI: 1S/C30H16O8/c1-7-3-9(31)19-23-15(7)16-8(2)4-10(32)20-24(16)28-26-18(12(34)6-14(36)22(26)30(20)38)17-11(33)5-13(35)21(29(19)37)25(17)27(23)28/h3-6,33-38H,1-2H3
• Isomeric SMILES: CC1=CC(=O)C2=C(C3=C(C=C(C4=C3C5=C2C1=C6C(=CC(=O)C7=C(C8=C(C=C(C4=C8C5=C67)O)O)O)C)O)O)O
• WGK Germany: 3
• Alternate CAS: 1372719-41-9,548-04-9
• NSC Number: 407313
• MeSH Entry Terms: 1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro(1,10,9,8-opqra)perylene-7,14-dione;hipericin;hypericin;hypericum red;mono-(123I)iodohypericin;SGX-301;SGX301
• Molecular Weight: 504.44
• Beilstein: 1917913
• Reaxy-Rn: 35831525
• Reaxys-RN_link_address: https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=35831525&ln=

Chemical and Physical Properties

• Sensitivity: Light sensitive.
• Molecular Weight: 504.400 g/mol
• XLogP3: 5.700
• Hydrogen Bond Donor Count: 6
• Hydrogen Bond Acceptor Count: 8
• Rotatable Bond Count: 0
• Exact Mass: 504.085 Da
• Monoisotopic Mass: 504.085 Da
• Topological Polar Surface Area: 156.000 Ų
• Heavy Atom Count: 38
• Formal Charge: 0
• Complexity: 1090.000
• Isotope Atom Count: 0
• Defined Atom Stereocenter Count: 0
• Undefined Atom Stereocenter Count: 0
• Defined Bond Stereocenter Count: 0
• Undefined Bond Stereocenter Count: 0
• The total count of all stereochemical bonds: 0
• Covalently-Bonded Unit Count: 1

References

1. Junyan Wang, Minmin Huang, Haihong Hu, Lushan Yu, Su Zeng.  (2014)  Pregnane X receptor-mediated transcriptional activation of UDP-glucuronosyltransferase 1A1 by natural constituents from foods and herbs.  FOOD CHEMISTRY,      [PMID:24996308] [10.1016/j.foodchem.2014.05.004]

2. Lei Xu, Jiahe Hu, Xiuwei Yan, Hongtao Zhao, Mo Geng, Jiheng Zhang, Chunxiao Zhou, Zhihui Liu, Bo Li, Shaoshan Hu.  (2024)  Overcoming therapeutic limitations in glioblastoma treatment: A nanocomposite inducing ferroptosis and oxeiptosis via Photodynamic therapy.  CHEMICAL ENGINEERING JOURNAL,      [PMID:] [10.1016/j.cej.2024.157405]